Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine add-on to olmesartan in moderately to severely hypertensive patients inadequately controlled on olmesartan 20 mg
2005-000447-28Phase 3Completed
- Sponsor
- Daiichi Sankyo
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of amlodipine and olmesartan in essential hypertension (3 arms), sponsored by Daiichi Sankyo. Started Jun 2005; status: completed.
02
Drugs
amlodipineolmesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2005-000447-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000447-28.